Table 3. Factors associated with missing at least four weeks of ART in the past year.
| Characteristic | Missed ≥4 weeks of ART, past year(N=49) n (%) |
Unadjusted OR (95% CI) |
p- value |
Adjusted OR (95% CI) |
p-value |
|---|---|---|---|---|---|
| Age | |||||
| ≤ 30 years | 7 (14.3) | 1.00 | |||
| 31 to 40 years | 15 (30.6) | 0.91 (0.36–2.30) | 0.844 | ||
| ≥ 41 years | 27 (55.1) | 1.78 (0.75–4.22) | 0.188 | ||
| Sex | |||||
| Female | 14 (28.6) | 1.00 | 1.00 | ||
| Male | 35 (71.4) | 1.70 (0.90–3.23) | 0.103 | 2.06 (1.07–3.96)* | 0.031 |
| Residence | |||||
| Guangzhou | 17 (36.2) | 1.00 | |||
| Other, Guangdong | 30 (63.8) | 1.06 (0.57– 1.97) | 0.854 | ||
| Education | |||||
| ≥ Post-secondary | 1 (2.0) | 1.00 | 1.00 | ||
| High school | 5 (10.2) | 2.94 (0.34–25.58) | 0.329 | 3.03 (0.35–26.57)* | 0.318 |
| Middle school | 23 (46.9) | 6.23 (0.83–46.83) | 0.076 | 6.55 (0.87–49.64)* | 0.069 |
| ≤ Primary school | 20 (40.8) | 12.82 (1.69–97.42) | 0.014 | 14.31 (1.86–110.27)* | 0.011 |
| Employment | |||||
| Full-time | 8 (16.3) | 1.00 | |||
| Part-time or temporary | 16 (32.7) | 2.57 (1.07–6.16)* | 0.035 | ||
| Retired | 2 (4.1) | 1.28 (0.26–6.25) | 0.763 | ||
| No employment | 23 (46.9) | 2.47 (1.08–5.64)* | 0.032 | ||
| Cohabitating | |||||
| Yes | 29 (59.2) | 1.00 | |||
| No | 20 (40.8) | 1.15 (0.64-2.08) | 0.643 | ||
| Alcohol | |||||
| None | 34 (70.8) | 1.00 | |||
| Several times a month | 11 (22.9) | 1.60 (0.78–3.26) | 0.200 | ||
| Several times a week | 3(6.3) | 2.05 (0.58–7.22) | 0.264 | ||
| IV drug use, past month | |||||
| No | 43 (95.6) | 1.00 | |||
| Yes | 2 (4.4) | 1.21 (0.28–5.34) | 0.800 | ||
| Most recent sex partner, past 3 months | |||||
| No partner | 4 (16.0) | 1.00 | |||
| Steady partner | 20 (80.0) | 1.05 (0.35–3.20) | 0.929 | ||
| Casual partner | 1 (4.0) | 1.58 (0.19– 13.08) | 0.673 | ||
| Condoms at last intercourse | |||||
| Yes | 21 (84.0) | 1.00 | |||
| No | 4 (16.0) | 0.91 (0.30–2.74) | 0.865 | ||
| HIV transmission route | |||||
| Heterosexual sex | 18 (37.5) | 1.00 | |||
| Homosexual sex | 7 (14.6) | 1.59 (0.63–3.99) | 0.323 | ||
| Intravenous drug use | 9 (18.8) | 1.00 (0.43–2.28) | 0.992 | ||
| Transfusion | 5 (10.4) | 0.94 (0.34–2.62) | 0.903 | ||
| Not sure/other | 9 (18.8) | 0.86 (0.38– 1.98) | 0.727 | ||
| Received risk reduction counseling at ART initiation | |||||
| Yes | 46 (93.9) | 1.00 | |||
| No | 3 (6.1) | 0.58 (0.17–1.91) | 0.369 | ||
| Most recent CD4 count | |||||
| ≥ 200 cells/mm3 | 34 (69.4) | 1.00 | |||
| < 200 cells/mm3 | 15 (30.6) | 1.03 (0.55– 1.93) | 0.936 | ||
| Time on ART | |||||
| < 1 year | 11 (22.5) | 1.00 | 1.00 | ||
| 1 to 3 years | 26 (53.1) | 2.14 (1.03–4.43)* | 0.042 | 1.91 (0.91–4.01)* | 0.088 |
| > 3 years | 12 (24.5) | 1.26 (0.54–2.93) | 0.588 | 1.15 (0.49–2.72) | 0.742 |
| Tested positive, any STD | |||||
| No | 44 (89.8) | 1.00 | |||
| Yes | 5 (10.2) | 1.15 (0.44–3.02) | 0.776 |
*
Statistically significant at the p<0.1 level